Effectiveness of biologics for treating psoriasis: a meta-analysis of real-world evidence
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: LIN, Pei-Tzu (Chiayi Chang Gung Memorial Hospital of the C.G.M.F., Department of Pharmacy)
- Co-author(s): Pei-Tzu Lin: Department of Pharmacy, Chiayi Chang Gung Memorial Hospital of the C.G.M.F., Chiayi, Taiwan, Province of China
Shu-Hui Wang: Department of Dermatology, Far Eastern Memorial Hospital, New Taipei, Taiwan, Province of China
Ching-Chi Chi: Department of Dermatology, Linkou Chang Gung Memorial Hospital of the C.G.M.F., Taoyuan, Taiwan, Province of China
The efficacy of biologics in treating psoriasis usually fades with time. Drug survival of biologics represent the long- term effectiveness and safety of the biologics in the real world and is a useful reference for choosing a biologic for treating psoriasis.
We searched the PubMed, CENTRAL, and EMBASE from inception to The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.